Faraday Future, led by Jia Yueting, has invested in QLGN through a $41 million PIPE deal in collaboration with the Sign Foundation to launch its crypto assets business.

2025-09-20 02:20:21

Abstract generation in progress

According to BlockBeats news, on September 20, Faraday Future (NASDAQ: FFAI) announced today that it will strategically invest in Qualigen Therapeutics (NASDAQ: QLGN) through a $41 million PIPE transaction, which will be renamed CXC10 and transform into an encryption and Web3 business platform. The lineup of investors is strong, including not only Faraday Future and Jia Yueting personally but also Sign, a blockchain technology company that builds on-chain public infrastructure for governments and enterprises globally, providing secure solutions ranging from digital identity verification to Token distribution.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share